In an exploratory open-label trial of 185 patients with primary insomnia or depressive/bipolar depressive episodes with insomnia, dimdazenil 2.5 mg gave a mean subjective total sleep time 7.36 min longer than midazolam 15 mg at day 14; no significance test was reported.
RCTn = 185
Dun et al. Efficacy and safety of Dimdazenil in primary insomnia and depressive episodes/bipolar depressive episode with insomnia: A post-marketing, randomized, open-label, positive-controlled study